Cytokine profile in first-episode drug-naïve major depressive disorder patients with or without anxiety

Abstract Objective It is known that cytokines play a role in both depression and anxiety. This study aimed to compare the levels of multiple cytokines in patients with first-episode drug-naive major depressive disorder (MDD) with or without anxiety and analyze the correlation between the level of de...

Full description

Bibliographic Details
Main Authors:	Jun Liang, Yayun Xu, Wenfan Gao, Yanhong Sun, Yuanyuan Zhang, Feng Shan, Qingrong Xia
Format:	Article
Language:	English
Published:	BMC 2024-02-01
Series:	BMC Psychiatry
Subjects:	Cytokines Serum Major depressive disorder Anxiety Correlation
Online Access:	https://doi.org/10.1186/s12888-024-05536-2

Similar Items

Peripheral blood cytokines as potential diagnostic biomarkers of suicidal ideation in patients with first-episode drug-naïve major depressive disorder
by: Yayun Xu, et al.
Published: (2022-11-01)

Effect of duloxetine on changes in serum proinflammatory cytokine levels in patients with major depressive disorder
by: Wenfan Gao, et al.
Published: (2024-06-01)

Prospective study on Maresin-1 and cytokine levels in medication-naïve adolescents with first-episode major depressive disorder
by: Tian Qiu, et al.
Published: (2023-03-01)

Gender differences in risk factors for suicide attempts among young, first-episode and drug-naive major depressive disorder patients with anxiety symptoms
by: Donghong Jiang, et al.
Published: (2024-08-01)

Gender differences in the association between anxiety symptoms and thyroid hormones in young patients with first-episode and drug naïve major depressive disorder
by: Ying Zhao, et al.
Published: (2023-08-01)

The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder
by: Jiamei Guo, et al.
Published: (2024-04-01)

Gender differences in prevalence and clinical correlates of anxiety in first-episode and drug-naïve patients with major depressive disorder comorbid with metabolic syndrome
by: Wenqi Gao, et al.
Published: (2024-02-01)

Prevalence and clinical correlates of abnormal lipid metabolism in older Chinese patients with first-episode drug-naïve major depressive disorder
by: Xiao Huang, et al.
Published: (2024-07-01)

The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression
by: Reiji Yoshimura, et al.
Published: (2023-02-01)

Association between inflammatory cytokines and symptoms of major depressive disorder in adults
by: Xue Min, et al.
Published: (2023-02-01)

Prevalence and clinical correlates of suicide attempts in patients with first-episode drug-naïve major depressive disorder and comorbid autoimmune thyroiditis
by: Yinli Luo, et al.
Published: (2024-05-01)

Serum Cytokine Levels and Anxiety and Depression Rates in Patients with Alopecia Areata
by: Arzu Ataseven, et al.
Published: (2011-08-01)

Association of inflammation cytokines with cognitive function in first-episode major depressive disorder
by: Yan Qing Xi, et al.
Published: (2025-01-01)

Analysis of EEG features and study of automatic classification in first-episode and drug-naïve patients with major depressive disorder
by: Yuanyuan Huang, et al.
Published: (2023-11-01)

Relationship between serum inflammatory cytokines and suicide risk in patients with major depressive disorder
by: Yiyue Yang, et al.
Published: (2024-06-01)

Comparison of cognitive function in patients with treatment-resistant depression and drug-naive first-episode major depressive disorder
by: Zheng Chaodun, et al.
Published: (2021-10-01)

Serum CC Chemokines as Potential Biomarkers for the Diagnosis of Major Depressive Disorder
by: Gao W, et al.
Published: (2022-10-01)

IMPACT OF CYTOKINES UPON COMORBID STATES OF CORONARY ARTERY DISEASE AND AFFECTIVE DISORDERS ASSOCIATED WITH DEPRESSION AND ANXIETY
by: S. N. Kozlova, et al.
Published: (2014-07-01)

Development and validation of a nomogram for suicide attempts in patients with first-episode drug-naïve major depressive disorder
by: Junjun Liu, et al.
Published: (2024-06-01)

Factors contributing to anxiety in adolescents surviving thalassemia major in Indonesia
by: Henny Suzana Mediani, et al.
Published: (2025-01-01)

Volumetric assessment of individual thalamic nuclei in patients with drug-naïve, first-episode major depressive disorder
by: Enkhmurun Chibaatar, et al.
Published: (2023-03-01)

Thyroid dysfunction in young, first-episode and drug-naïve patients with major depressive disorder: prevalence and associated clinical factors
by: Jinbo Wu, et al.
Published: (2023-06-01)

Dynamic Impact of the Sleep Disorder, Depression and Anxiety on the Cognitive Function in the First-Episode Depressive Patients
by: Zhang W, et al.
Published: (2025-02-01)

Identifying circulating biomarkers for major depressive disorder
by: En Zhang, et al.
Published: (2023-08-01)

Elevated Specific Pro-Inflammatory Cytokines in Peripheral Circulation Indicate an Increased Risk of Anxiety and Depression in Rosacea
by: Yang X, et al.
Published: (2024-07-01)

Prevalence and risk factors for psychotic symptoms in young, first-episode and drug-naïve patients with major depressive disorder
by: Yuxuan Wu, et al.
Published: (2024-01-01)

Cytokine profile in patients with chronic myeloid leukemia
by: T. N. Aleksandrova, et al.
Published: (2024-01-01)

Hemolacria secondary to major depressive disorder and generalized anxiety disorder: A case report
by: Leila Razeghian Jahromi, et al.
Published: (2023-11-01)

Serum zinc and copper levels in maintenance haemodialysis patients and its relationship with depression and anxiety
by: R Sudha, et al.
Published: (2015-08-01)

Association and interaction between overweight/obesity and suicide attempts in young first-episode and drug-naïve patients with major depressive disorder
by: Quanfeng Zhu, et al.
Published: (2024-11-01)

Evaluation of Inflammatory Markers in Patients with Depressed Episodes in Major Depressive Disorder and Bipolar Disorder before and after Treatment
by: Laya Kafami, et al.
Published: (2023-04-01)

CHARACTERISTICS OF NEUROPEPTIDE-CYTOKINE IMMUNITY LINKS IN PATIENTS WITH COMBINED CARDIOVASCULAR PATHOLOGY, PROCEEDING WITH ANXIETY/DEPRESSION DISORDER
by: A. V. Gertsev, et al.
Published: (2018-03-01)

The Cytokine, Chemokine, and Growth Factor Network of Prenatal Depression
by: Michael Maes, et al.
Published: (2023-04-01)

Suicide attempt rate and the risk factors in young, first-episode and drug-naïve Chinese Han patients with major depressive disorder
by: Gang Ye, et al.
Published: (2022-09-01)

Association between triglyceride glucose index and suicide attempts in patients with first-episode drug-naïve major depressive disorder
by: Junjun Liu, et al.
Published: (2023-07-01)

Co-expression network of mRNA and DNA methylation in first-episode and drug-naive adolescents with major depressive disorder
by: Yuanmei Tao, et al.
Published: (2023-02-01)

Association of thyroid function with abnormal lipid metabolism in young patients with first-episode and drug naïve major depressive disorder
by: Jieqiong Hu, et al.
Published: (2023-02-01)

Clinical correlates and thyroid hormones of metabolic syndrome in first-episode and drug-naïve major depressive disorder outpatients with and without hyperglycemia: a comprehensive cross-sectional study
by: Siyang Zheng, et al.
Published: (2023-09-01)

Analysis of the relationship between pain, anxiety, depression, and self-care agency in patients who underwent major orthopedic surgeries
by: Bilsev Demir, et al.
Published: (2023-06-01)

Sex differences in prevalence and clinical correlates of subclinical hypothyroidism in Chinese patients with first-episode untreated major depressive disorder
by: Junqiang Cui, et al.
Published: (2025-01-01)